Clinical Trials · NCT02507492
RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Charite University, Berlin, Germany
- Enrollment
- 10
- Start date
- Jan 2015
- Locations
- 1 site, Germany
- Primary endpoint
- Effect of RM-493 on Body weight